Hoemann M - Search Results

1

Synthesis and optimization of furano[3,2-d]pyrimidines as selective spleen tyrosine kinase (Syk) inhibitors.

Hoemann M, Wilson N, Argiriadi M, Banach D, Burchat A, Calderwood D, Clapham B, Cox P, Duignan DB, Konopacki D, Somal G, Vasudevan A. Hoemann M, et al. Bioorg Med Chem Lett. 2016 Nov 15;26(22):5562-5567. doi: 10.1016/j.bmcl.2016.09.077. Epub 2016 Oct 11. Bioorg Med Chem Lett. 2016. PMID: 27789138

2

Design strategies to address kinetics of drug binding and residence time.

Cusack KP, Wang Y, Hoemann MZ, Marjanovic J, Heym RG, Vasudevan A. Cusack KP, et al. Among authors: hoemann mz. Bioorg Med Chem Lett. 2015;25(10):2019-27. doi: 10.1016/j.bmcl.2015.02.027. Epub 2015 Mar 5. Bioorg Med Chem Lett. 2015. PMID: 25782745 Review.

3

Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat Pancreas.

Long AJ, Sampson E, McCarthy RW, Harris CM, Barnard M, Shi D, Conlon D, Caldwell R, Honor D, Wishart N, Hoemann M, Duggan L, Fritz D, Stedman C, O'Connor E, Mikaelian I, Schwartz A. Long AJ, et al. Among authors: hoemann m. Toxicol Pathol. 2016 Oct;44(7):998-1012. doi: 10.1177/0192623316654015. Epub 2016 Jun 19. Toxicol Pathol. 2016. PMID: 27324990

4

Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.

George DM, Huntley RJ, Cusack K, Duignan DB, Hoemann M, Loud J, Mario R, Melim T, Mullen K, Somal G, Wang L, Edmunds JJ. George DM, et al. Among authors: hoemann m. PLoS One. 2018 Sep 7;13(9):e0203567. doi: 10.1371/journal.pone.0203567. eCollection 2018. PLoS One. 2018. PMID: 30192846 Free PMC article.

5

Identification of potent and selective inhibitors of PKR via virtual screening and traditional design.

Cusack KP, Argiriadi MA, Gordon TD, Harris CM, Herold JM, Hoemann MZ, Yestrepsky BD. Cusack KP, et al. Among authors: hoemann mz. Bioorg Med Chem Lett. 2023 Jan 1;79:129047. doi: 10.1016/j.bmcl.2022.129047. Epub 2022 Nov 15. Bioorg Med Chem Lett. 2023. PMID: 36400288

6

Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives.

Hoemann MZ, Kumaravel G, Xie RL, Rossi RF, Meyer S, Sidhu A, Cuny GD, Hauske JR. Hoemann MZ, et al. Bioorg Med Chem Lett. 2000 Dec 4;10(23):2675-8. doi: 10.1016/s0960-894x(00)00542-4. Bioorg Med Chem Lett. 2000. PMID: 11128649

7

Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives.

Hoemann MZ, Xie RL, Rossi RF, Meyer S, Sidhu A, Cuny GD, Hauske JR. Hoemann MZ, et al. Bioorg Med Chem Lett. 2002 Jan 21;12(2):129-32. doi: 10.1016/s0960-894x(01)00714-4. Bioorg Med Chem Lett. 2002. PMID: 11755337

8

Butitaxel analogues: synthesis and structure-activity relationships.

Ali SM, Hoemann MZ, Aubé J, Georg GI, Mitscher LA, Jayasinghe LR. Ali SM, et al. Among authors: hoemann mz. J Med Chem. 1997 Jan 17;40(2):236-41. doi: 10.1021/jm960505t. J Med Chem. 1997. PMID: 9003522

9

Novel cytotoxic 3'-(tert-butyl) 3'-dephenyl analogs of paclitaxel and docetaxel.

Ali SM, Hoemann MZ, Aubé J, Mitscher LA, Georg GI, McCall R, Jayasinghe LR. Ali SM, et al. Among authors: hoemann mz. J Med Chem. 1995 Sep 15;38(19):3821-8. doi: 10.1021/jm00019a012. J Med Chem. 1995. PMID: 7562913

10

Biological properties of novel antistaphylococcal quinoline-indole agents.

Oliva B, Miller K, Caggiano N, O'Neill AJ, Cuny GD, Hoemann MZ, Hauske JR, Chopra I. Oliva B, et al. Among authors: hoemann mz. Antimicrob Agents Chemother. 2003 Feb;47(2):458-66. doi: 10.1128/AAC.47.2.458-466.2003. Antimicrob Agents Chemother. 2003. PMID: 12543644 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page